Smith & Nephew PLC ADR (SNN) News

Smith & Nephew PLC ADR (SNN): $25.32

0.07 (+0.28%)

POWR Rating

Component Grades








Filter SNN News Items

SNN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest SNN News From Around the Web

Below are the latest news stories about SMITH & NEPHEW PLC that investors may wish to consider to help them evaluate SNN as an investment opportunity.

Is Smith & Nephew plc (LON:SN.) Trading At A 40% Discount?

Key Insights Smith & Nephew's estimated fair value is UK£17.05 based on 2 Stage Free Cash Flow to Equity Smith...

Yahoo | November 29, 2023

Smith & Nephew (SNN) New Buyout Expands Sports Medicine Suite

Smith & Nephew (SNN) will pay an initial cash consideration of $180 million at closure, with an additional $150 million based on financial performance to acquire CartiHeal.

Yahoo | November 28, 2023

Smith & Nephew inks $180M CartiHeal buyout, capitalizing on Bioventus turmoil to land knee implant

Bioventus’ protracted buyout bid ultimately fell apart and opened the door to Smith & Nephew.

Yahoo | November 27, 2023

After losing 1.8% in the past year, Smith & Nephew plc (LON:SN.) institutional owners must be relieved by the recent gain

Key Insights Significantly high institutional ownership implies Smith & Nephew's stock price is sensitive to their...

Yahoo | November 14, 2023

Shareholders in Smith & Nephew (LON:SN.) are in the red if they invested three years ago

As an investor its worth striving to ensure your overall portfolio beats the market average. But if you try your hand...

Yahoo | October 17, 2023

Smith+Nephew opens new state-of-the-art surgical innovation and training centre in the heart of Munich

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company specialising in orthopaedics, advanced wound management and sports medicine, is pleased to announce the opening of the purpose-built Smith+Nephew Academy Munich, a new centre for surgical innovation and training.

Yahoo | October 11, 2023

Smith & Nephew PLC: An In-depth Analysis of its Dividend Performance

Smith & Nephew PLC(NYSE:SNN) recently announced a dividend of $0.29 per share, payable on 2023-11-01, with the ex-dividend date set for 2023-10-05. Using the data from GuruFocus, let's deep dive into Smith & Nephew PLCs dividend performance and assess its sustainability. Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions.

Yahoo | October 5, 2023

The Zacks Analyst Blog Highlights Abbott Laboratories, Koninklijke Philips and Smith & Nephew

Abbott Laboratories, Koninklijke Philips and Smith & Nephew are included in this Analyst Blog.

Yahoo | October 3, 2023

Smith & Nephew's (LON:SN.) Returns On Capital Not Reflecting Well On The Business

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Yahoo | October 2, 2023

3 Medical Product Stocks With Solid Dividend Yield: ABT & Others

Here we pick three stocks, Abbott Laboratories (ABT), Koninklijke Philips (PHG) and Smith & Nephew SNATS (SNN) from the Medical - Products industry, with a solid five-year dividend growth history.

Yahoo | October 2, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!